Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP700881.RA56jiEdg8vg9sn7gdBUHvGfZmylBPLrGEh8qw5JaEBr8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP700881.RA56jiEdg8vg9sn7gdBUHvGfZmylBPLrGEh8qw5JaEBr8130_assertion type Assertion NP700881.RA56jiEdg8vg9sn7gdBUHvGfZmylBPLrGEh8qw5JaEBr8130_head.
- NP700881.RA56jiEdg8vg9sn7gdBUHvGfZmylBPLrGEh8qw5JaEBr8130_assertion description "[Vesicular monoamine transporter subtype 2 (VMAT2) activity protects against neurotoxins, and reduced VMAT2 expression is implicated in drug addiction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP700881.RA56jiEdg8vg9sn7gdBUHvGfZmylBPLrGEh8qw5JaEBr8130_provenance.
- NP700881.RA56jiEdg8vg9sn7gdBUHvGfZmylBPLrGEh8qw5JaEBr8130_assertion evidence source_evidence_literature NP700881.RA56jiEdg8vg9sn7gdBUHvGfZmylBPLrGEh8qw5JaEBr8130_provenance.
- NP700881.RA56jiEdg8vg9sn7gdBUHvGfZmylBPLrGEh8qw5JaEBr8130_assertion SIO_000772 14730204 NP700881.RA56jiEdg8vg9sn7gdBUHvGfZmylBPLrGEh8qw5JaEBr8130_provenance.
- NP700881.RA56jiEdg8vg9sn7gdBUHvGfZmylBPLrGEh8qw5JaEBr8130_assertion wasDerivedFrom befree-20150227 NP700881.RA56jiEdg8vg9sn7gdBUHvGfZmylBPLrGEh8qw5JaEBr8130_provenance.
- NP700881.RA56jiEdg8vg9sn7gdBUHvGfZmylBPLrGEh8qw5JaEBr8130_assertion wasGeneratedBy ECO_0000203 NP700881.RA56jiEdg8vg9sn7gdBUHvGfZmylBPLrGEh8qw5JaEBr8130_provenance.